EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Guanylate-Binding Protein 1 (GBP1) Enhances IFN-α Mediated Antiviral Activity against Hepatitis B Virus Infection

Yadi Li, Haiying Luo, Xiaoxia Hu, Jiaojiao Gong, Guili Tan, Huating Luo, Rui Wang, Hao Pang, Renjie Yu, Bo Qin

Polish Journal of Microbiology · 01.06.2024 · 73 (2) · 217-235

DOI: 10.33073/pjm-2024-021 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Polish Journal of Microbiology, online erschienen am 20.06.2024. Verfasst von Yadi Li und 9 weiteren Autor:innen. Beteiligte Einrichtung: 1Department of Infectious Diseases, Chongqing Key Laboratory of Infectious Diseases and Parasitic Diseases, The First Affiliated Hospital of Chongqin…. Hauptthemen laut MEDLINE: Interferon-alpha, Hepatitis B virus, Antiviral Agents, GTP-Binding Proteins. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Interferon-alpha (IFN-α) is a first-line drug for treating chronic hepatitis B (CHB). Guanylate-binding protein 1 (GBP1) is one of the interferon-stimulating factors, which participates in the innate immunity of the host and plays an antiviral and antibacterial role. In this study, we explored how GBP1 is involved in IFN-α antiviral activity against HBV. Before being gathered, HepG2-NTCP and HepG2 2.15 cells were transfected with the wild-type hGBP1 plasmid or si-GBP1, respectively, and followed by stimulation with Peg-IFNα-2b. We systematically explored the role of GBP1 in regulating HBV infection in cell models. Additionally, we also examined GBP1 levels in CHB patients. GBP1 activity increased, and its half-life was prolonged after HBV infection. Overexpression of GBP1 inhibited the production of HBsAg and HBeAg, as well as HBs protein and HBV total RNA levels, whereas silencing of GBP1 inhibited its ability to block viral infections. Interestingly, overexpressing GBP1 co-treatment with Peg-IFNα-2b further increased the antiviral effect of IFN-α, while GBP1 silencing co-treatment with Peg-IFNα-2b partly restored its inhibitory effect on HBV. Mechanistically, GBP1 mediates the anti-HBV response of Peg-IFNα-2b by targeting HBs. Analysis of clinical samples revealed that GBP1 was elevated in CHB patients and increased with Peg-IFNα-2b treatment, while GBP1 showed good stability in the interferon response group. Our study demonstrates that GBP1 inhibits HBV replication and promotes HBsAg clearance. It is possible to achieve antiviral effects through the regulation of IFN-α induced immune responses in response to HBV.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Interferon-alphaHepatitis B virusAntiviral AgentsGTP-Binding ProteinsHepatitis B, ChronicHumansHep G2 CellsMaleHepatitis B Surface AntigensFemaleAdultVirus ReplicationHepatitis B

Stichwörter der Autor:innen

antiviralchronic hepatitis Bguanylate-binding protein 1 (GBP1)hepatitis B surface antigenhepatitis B viruspegylated interferon α-2b

Substanzen

Interferon-alphaGBP1 protein, humanAntiviral AgentsGTP-Binding ProteinsHepatitis B Surface Antigens

Autor:innen und Institutionen

  • 1Department of Infectious Diseases, Chongqing Key Laboratory of Infectious Diseases and Parasitic Diseases, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
  • 2Central Laboratory, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
  • 3Department of Geriatrics, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.

Zitieren

APA

Li, Y., Luo, H., Hu, X., Gong, J., Tan, G., Luo, H., Wang, R., Pang, H., Yu, R., & Qin, B. (2024). Guanylate-Binding Protein 1 (GBP1) Enhances IFN-α Mediated Antiviral Activity against Hepatitis B Virus Infection. Polish Journal of Microbiology, 73(2), 217-235. https://doi.org/10.33073/pjm-2024-021

Vancouver

Li Y, Luo H, Hu X, Gong J, Tan G, Luo H, et al. Guanylate-Binding Protein 1 (GBP1) Enhances IFN-α Mediated Antiviral Activity against Hepatitis B Virus Infection. Polish Journal of Microbiology. 2024;73(2):217-235. doi:10.33073/pjm-2024-021

BibTeX
@article{Li2024,
  author = {Li, Yadi and Luo, Haiying and Hu, Xiaoxia and Gong, Jiaojiao and Tan, Guili and Luo, Huating and Wang, Rui and Pang, Hao and Yu, Renjie and Qin, Bo},
  title = {Guanylate-Binding Protein 1 (GBP1) Enhances IFN-α Mediated Antiviral Activity against Hepatitis B Virus Infection},
  journal = {Polish Journal of Microbiology},
  year = {2024},
  volume = {73},
  number = {2},
  pages = {217--235},
  doi = {10.33073/pjm-2024-021}
}
Kostenlos starten →